Stockopedia rates Kala Pharmaceuticals Inc as a Adventurous Sucker Stock . 3 brokers rate it as a 'Strong Buy'. Click to view NSQ:KALA's StockReport.
Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
The company’s stock price has collected -22.87% of loss in the last five trading sessions. Press Release reported on 03/18/21 that Kala Pharmaceuticals Reports I Funds that own Kala Pharmaceuticals also own: Vertex Pharmaceuticals Incorporated (VRTX) Ascendis Pharma A S (ASND) Zogenix (ZGNX) Eiger Biopharmaceuticals (EIGR) Iveric Bio Inc (ISEE) Novavax, Inc. (NVAX) Turning Point Therapeutics I (TPTX) Black Diamond Therapeutics Inc (BDTX) Sierra Oncology Inc (SRRA) Trane Technologies Plc Shs stock (TT) The Kala Pharmaceuticals 52-week low stock price is 5.04, which is 43.6% below the current share price. The average Kala Pharmaceuticals stock price for the last 52 weeks is 8.95 . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide . Kala Pharmaceuticals, Inc. is focused on the development and commercialization of therapeutics using our proprietary AMPPLIFY ® Drug Delivery Technology, with an initial focus on the treatment of eye diseases. The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
stock was originally listed at a price of $18.49 in Jul 20, 2017. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -60.74%, for an annualized return of -26.77%. 2021-04-13 · Investors Who Bought Kala Pharmaceuticals (NASDAQ:KALA) Shares A Year Ago Are Now Up 105%. The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. On the other Kala is a Biopharmaceutical Company Committed To Advancing the treatment of eye diseases Kala Pharmaceuticals Inc stock price down 1.84% on Friday (Updated on April 16, 2021) Buy candidate since 2021-04-15 Loss -1.84% PDF The Kala Pharmaceuticals Inc stock price fell by -1.84% on the last day (Friday, 16th Apr 2021) from $7.61 to $7.47. During the day the stock fluctuated 4.80% from a day low at $7.29 to a day high of $7.64.
Get Kala Pharmaceuticals Inc (KALA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Data is currently not available. $7.57. +0.31 (+4.27%) DATA AS OF Apr 09, 2021. Add to Watchlist.
A high-level overview of Kala Pharmaceuticals, Inc. (KALA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. KALA: Get the latest Kala Pharmaceuticals stock price and detailed information including KALA news, historical charts and realtime prices. Investors Who Bought Kala Pharmaceuticals (NASDAQ:KALA) Shares A Year Ago Are Now Up 105% The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. On the other Where Does Wall Street Think Kala Pharmaceuticals Inc (KALA) Stock Will Go? at InvestorsObserver.comMon, Mar. 29 Is it Time to Dump Kala Pharmaceuticals Inc (KALA) Stock After it Has Fallen 14.22% View Kala Pharmaceuticals, Inc. KALA investment & stock information. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Kala Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch. Kala Pharmaceuticals, Inc. Common Stock (KALA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
2021-04-16 · View Kala Pharmaceuticals, Inc. KALA investment & stock information. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Class a1 moped
Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. KALA PHARMACEUTICALS, INC. : News, information and stories for KALA PHARMACEUTICALS, INC. | Nasdaq: KALA | Nasdaq 2021-02-26 · Kala Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch. Kala Pharmaceuticals market cap is $393.9 m..
View real-time stock prices and stock quotes for a full financial overview. Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Kala Pharmaceuticals NASDAQ Updated Apr 9, 2021 11:54 PM. KALA 7.57 0.31 (4.27%).
Arv utan barn
how to extend lockout wow
läkare karolinska
riskanalytiker lon
vad har jag för clearingnr swedbank
hippos colombia
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock …
The company’s stock price has collected -22.87% of loss in the last five trading sessions. Press Release reported on 03/18/21 that Kala Pharmaceuticals Reports I Funds that own Kala Pharmaceuticals also own: Vertex Pharmaceuticals Incorporated (VRTX) Ascendis Pharma A S (ASND) Zogenix (ZGNX) Eiger Biopharmaceuticals (EIGR) Iveric Bio Inc (ISEE) Novavax, Inc. (NVAX) Turning Point Therapeutics I (TPTX) Black Diamond Therapeutics Inc (BDTX) Sierra Oncology Inc (SRRA) Trane Technologies Plc Shs stock (TT) The Kala Pharmaceuticals 52-week low stock price is 5.04, which is 43.6% below the current share price. The average Kala Pharmaceuticals stock price for the last 52 weeks is 8.95 .
Asiatisk restaurang norrtälje
key solutions flashback
- Fragor till polisen
- Bmc 100 massage table
- Dans västerås 2021
- Karlshamn spelutveckling
- Eslov bergagymnasiet
- Åkers krutbruk
- Svetsare oljeplattform lon
- Hypernephroma ultrasound
- Volvo v40 konkurrenter
- Geriatrik växjö
Kala Pharmaceuticals (NASDAQ:KALA) Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months.
Find the latest Kala Pharmaceuticals, Inc. (KALA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 2021-02-26 · Kala Pharmaceuticals Inc. company facts, information and financial ratios from MarketWatch. 2021-03-30 · Kala Pharmaceuticals Inc. (NASDAQ:KALA) went down by -11.11% from its latest closing price compared to the recent 1-year high of $14.68.
2021-04-12
08:43 Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards Feb 15, 2021 With a market capitalization of US$484m, Kala Pharmaceuticals is a small cap stock, so it might not be well known by many institutional Dec 26, 2020 The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. On the other hand, if you View a financial market summary for KALA including stock price quote, trading volume, volatility, options volume, statistics, and other important company data Start a 14-day free trial to Morningstar Premium to unlock our take on KALA. Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative Stock Type Distressed. In depth view into KALA (Kala Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials. Stockopedia rates Kala Pharmaceuticals Inc as a Adventurous Sucker Stock .
Click to view NSQ:KALA's StockReport. --(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary Information on stock, financials, earnings, subsidiaries, investors, and executives for Kala Pharmaceuticals.